Papageorgiou Hospital
- Address
- Agiou pavlou 76, Thessaloniki, Greece
Papageorgiou Hospital - Oncology & Thrombosis Research
Papageorgiou Hospital is actively engaged in advancing cancer care through specialized research in oncology and thrombotic complications. The center focuses on improving outcomes for patients with advanced pancreatic cancer, addressing one of the most challenging malignancies in contemporary oncology.
- Thromboprophylaxis strategies in advanced cancer patients
- Progression-free survival optimization in metastatic pancreatic cancer
- Venous thromboembolism (VTE) prevention during chemotherapy
The research center is particularly invested in understanding the relationship between anticoagulation therapy and cancer outcomes, conducting prospective studies that evaluate the integration of long-term thromboprophylaxis with first-line chemotherapy regimens. Their work aims to establish evidence-based protocols for VTE prevention that may simultaneously improve survival outcomes in patients with locally advanced or metastatic disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Papageorgiou Hospital
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of Oral Cladribine Tablets on Immune Synapse Molecules in Relapsing Multiple Sclerosis Patients: A 12‑Month Comparative Study | Aristotle University Of Thessaloniki | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cladribine | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.